28 reports

  • Cardiovascular Drugs Market Forecast Growth
  • Cardiovascular Drugs Market Segmentation
  • Cardiovascular Drug
  • World
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • Import of Western Cardiovascular Drugs
  • Cardiovascular Drugs Producers Output and Their
  • Cardiovascular Drug
  • China
  • Supply
  • Bristol-Myers Squibb Company
  • Tasly Pharmaceutical Co., Ltd.
  • The Western Cardiovascular Drugs Producers and
  • Import of Western Cardiovascular Drugs
  • Cardiovascular Drug
  • Therapy
  • China
  • Supply
  • Tasly Pharmaceutical Co., Ltd.

Global Cardiovascular Drugs Market Analysis and Forecasts, By Drug Class ##. ##.

  • Cardiovascular Drug
  • Therapy
  • World
  • Market Size
  • Cardiovascular Drugs Companies in China
  • Cardiovascular Drugs Industry Structure
  • Cardiovascular Drug
  • China
  • Bristol-Myers Squibb Company
  • Tasly Pharmaceutical Co., Ltd.
  • Zhejiang Expressway Co., Ltd.
  • Cardiovascular Drugs Production and Demand
  • Chapter IV
  • Cardiovascular Drug
  • Prescription Drug
  • China
  • Demand
  • Supply
  • Cardiovascular Drugs
  • Cardiovascular Drug
  • China
  • Demand
  • Forecast
  • Market Size
  • Cardiovascular Drugs Production and Demand
  • Chapter IV
  • Cardiovascular Drug
  • China
  • Demand
  • Supply
  • Zhejiang Expressway Co., Ltd.

Since high glucose level severely affects the cardiovascular health of a person, the region is expected to witness an increased demand for cardiovascular drugs, especially angina pectoris drugs.

  • Beta-Blocker
  • Cardiovascular Drug
  • AstraZeneca PLC
  • Gilead Sciences, Inc.
  • Novartis AG
  • DAIICHI-SANKYO SWOT ANALYSIS, 2016
  • BAYER SWOT ANALYSIS, 2016
  • Cardiovascular Drug
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Daiichi Sankyo Company
  • Pfizer Inc.

This is expected to boost the demand for cardiovascular drugs, which, in turn, drives the demand for heart failure drugs in the region.

  • Beta-Blocker
  • Cardiovascular Drug
  • Amgen Inc.
  • AstraZeneca PLC
  • Novartis AG

It is also observed that these cases of joint replacements and cardiovascular procedures are more commonly observed among the older population.

  • Cardiovascular Drug
  • Boehringer Ingelheim GmbH
  • Daiichi Sankyo Company
  • Johnson & Johnson
  • Sanofi S.A.
  • Sanofi

For instance, the company collaborated with Bristol-Myers Squibb to develop and comarket novel cardiovascular drugs.

  • Cardiovascular Drug
  • Market Size
  • Boehringer Ingelheim GmbH
  • F. Hoffmann-La Roche Ltd.
  • Sanofi S.A.

Growing focus of vendors to explore new areas in cardiovascular therapies like gene that target to relieve a specific symptom will drive the market growth.

  • Cardiovascular Drug
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • 9.1 OVERVIEW

AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS; ##(##): ##-##.

  • Cardiovascular Drug
  • World
  • Amgen Inc.
  • AstraZeneca PLC
  • Eli Lilly & Co.

CURRENTLY, CHINA HAS MORE THAN ##, ## CHEMICAL MEDICINE FACTORIES, AND CAN PRODUCE ## KINDS OF MEDICINE, SUCH AS ANTIBIOTICS, SULFANILAMIDES, ANTIPYRETICS AND ANALGESICS, ANTICARCINOGEN AND CARDIOVASCULAR DRUGS, ##, ## SPECIES AND ##, ## VARIETIES OF DRUGS PREPARATION.

  • Cardiovascular Drug
  • China
  • Demand
  • Market Size
  • Sanofi-Synthelabo Inc.
  • 03.2 Product Offerings

The company offers cardiovascular drugs, diabetes drugs, anti-cancer drugs, antihyperlipidemic agents, and OTC drugs.

  • Anti-Infective
  • Cardiovascular Drug
  • Japan
  • Meiji Seika Pharma Co., Ltd.
  • Nipro Corporation

Approval of Cardiovascular Drugs THE TOTAL US SALES FOR THE PAD THERAPEUTICS MARKET IN THE 2014 BASE YEAR WAS APPROXIMATELY $##. ##M.

  • Cardiovascular Drug
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • Sanofi S.A.
  • Clinical Trial profile. 21 Trial Title

Drug/ Molecule refers to Primary Intervention only. ##.

  • Cardiology
  • Cardiovascular Drug
  • Clinical Trial
  • World
  • Product Initiative

NANOFORM CARDIOVASCULAR THERAPEUTICS LTD Neurim Pharmaceuticals Ltd (Neurim) is a drug discovery company that develops drugs for central nervous system diseases.

  • Cardiovascular Drug
  • Hypertension
  • Pharmaceutical
  • United States
  • Product Initiative

Drug/ Molecule refers to Primary Intervention only. ##.

  • Cardiovascular Drug
  • Drug Discovery And Development
  • World
  • Product Initiative
  • Sanofi S.A.

Drug/ Molecule refers to Primary Intervention only. ##.

  • Cardiovascular Drug
  • Drug Discovery And Development
  • Pharmaceutical
  • World
  • Product Initiative

Sotalol hydrochloride is a cardiovascular drug.

  • Cardiovascular Drug
  • Therapy
  • World
  • Market Size
  • Product Initiative
  • 5. All the trials included are unique trials.

Drug/ Molecule refers to Primary Intervention only. ##.

  • Cardiovascular Drug
  • Drug Discovery And Development
  • Hypertension
  • World
  • Novartis AG

Drug/ Molecule refers to Primary Intervention only. ##.

  • Cardiovascular Disease
  • Cardiovascular Drug
  • Drug Discovery And Development
  • World
  • AstraZeneca PLC

DRUG/ MOLECULE REFERS TO PRIMARY INTERVENTION ONLY. ##.

  • Cardiovascular Disease
  • Cardiovascular Drug
  • Chronic Disease
  • Pharmaceutical
  • World

PACT Admiral Drug-eluting Balloon in a Chinese Patient Population GDCT## NCT##, Cardiovascular Atherosclerosis Completed Phase II Interventional IN.

  • Cardiovascular Disease
  • Cardiovascular Drug
  • Clinical Trial
  • Lipid Modifying Drug
  • World
  • EON 100 AUTOMATED CHEMISTRY ANALYZER - DIGOXIN ASSAY - PRODUCT DESCRIPTION

NUMBER OF PIPELINE PRODUCTS BY DEVELOPMENT STAGE EARLY DEVELOPMENT DISEASE SPECIFIC IMMUNOCHEMISTRY INACTIVE CARDIOVASCULAR TDM VITAL DIAGNOSTICS, INC.

  • Cardiovascular Drug
  • In Vitro Diagnostics
  • United States
  • World
  • Product Initiative